Evaluation of the predictive value of bioimpedance parameters on the clinical outcome of newly diagnosed cancer patients and patients undergoing first-line chemotherapy; trial involving 14 Italian oncology units.
Prof. Riccardo Caccialanza – Director of Multispecialty Dept. of Dietetics and Clinical Nutrition – Fondazione IRCCS Policlinico S. Matteo Hospital – Pavia
MD Paolo Pedrazzoli – Director of Oncology Dept., Fondazione IRCCS Policlinico S. Matteo Hospital – Pavia
Monocentric retrospective observational study
Research project aimed at the validation of the parameter as a predictive factor of mortality in oncological patients.
MD, PhD Emanuele Cereda – Doctor and Researcher, Fondazione IRCCS Policlinico S. Matteo Hospital – Pavia
Active tags: ONCOLOGY